8-K
Current Report
Oruka Therapeutics, Inc. Filed Acc 0001564590-21-017811
Material agreement · Director nominations
- Item 1.01 Entry into a material definitive agreement
- Item 5.08 Shareholder director nominations
From the SEC's structured data for this filing
Loading abio-8k_20210402.htm…